Venlon Enterprises Ltd
Venlon Enterprises Ltd (VENLONENT): company summary
The company's business is deteriorating, with annual net profit showing a loss of ₹3 crore, while revenue stood at ₹8 crore.
Venlon Enterprises Ltd (VENLONENT) is a micro-cap Chemicals company valued at ₹21 crore operating in Commodity Chemicals on the NSE and BSE.
- Recent price move
- Venlon Enterprises Ltd last traded at ₹3.95, unchanged on the day.
- Recent developments
- 2026-06-30: The company reported a net loss of ₹0 crore in the latest quarter, compared to a loss of ₹1 crore in the same quarter a year earlier. 2026-03-31: The company's financial year ended with a net loss of ₹3 crore, reflecting a widening loss from ₹1 crore in the prior year.
- Financial performance
- The company's business is deteriorating, with annual net profit showing a loss of ₹3 crore, while revenue stood at ₹8 crore. The latest quarter saw revenue fall 31.7% year-on-year to ₹1 crore, but the net loss narrowed to ₹0 crore from ₹1 crore in the same period a year ago.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -0.95 times book value.
- Things to watch
- The company is highly leveraged, with debt to equity at 5.86. Net profit margin is -42.5%, and return on equity is -88.6%, indicating poor profitability. The stock is 48.4% below its 52-week high, and the latest quarter's revenue fell 31.7% compared to the same quarter a year earlier.
- Where it stands
- Venlon Enterprises Ltd ended its latest quarter with a net loss of ₹0 crore, but the company reported a net loss of ₹3 crore in its latest financial year. The stock is 48.4% below its 52-week high, and the company's debt to equity ratio remains at 5.86.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.2), but held back by quality (0.3). Scored on 4 of 5 measures.
DocStoX score
Low confidenceScored on 4 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Revenue compounding 16% a year
- Loss-making — no meaningful P/E
- High leverage — debt is 5.9× equity
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Commodity Chemicals
Explore Venlon Enterprises Ltd’s valuation
Free deep-dive tools · no sign-up
Venlon Enterprises Ltd peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Venlon Enterprises Ltd with the ratios and calculators DocStoX uses in its analysis.

